PubRank

K Delasalle

Author PubWeight™ 25.38‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Clinical course of solitary extramedullary plasmacytoma. Radiother Oncol 1999 2.05
2 Primary dexamethasone treatment of multiple myeloma. Blood 1992 2.02
3 Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy. Int J Radiat Oncol Biol Phys 1998 1.56
4 Impact of complete remission with intensive therapy in patients with responsive multiple myeloma. Bone Marrow Transplant 2001 1.27
5 Curability of solitary bone plasmacytoma. J Clin Oncol 1992 1.20
6 CR represents an early index of potential long survival in multiple myeloma. Bone Marrow Transplant 2009 1.19
7 Rapid control of previously untreated multiple myeloma with bortezomib-lenalidomide-dexamethasone (BLD). Hematology 2010 1.18
8 Bortezomib in combination with thalidomide-dexamethasone for previously untreated multiple myeloma. Hematology 2007 1.14
9 Prognostic significance of magnetic resonance imaging of bone marrow in previously untreated patients with multiple myeloma. Ann Oncol 2005 1.13
10 Imaging of myeloma bone disease--implications for staging, prognosis and follow-up. Acta Oncol 2000 0.98
11 Prognostic value of cytogenetics in multiple myeloma. Br J Haematol 1998 0.96
12 Solitary plasmacytoma of bone and asymptomatic multiple myeloma. Hematol Oncol Clin North Am 1992 0.95
13 Fludarabine therapy in Waldenström's macroglobulinemia. Am J Med 1993 0.93
14 Clinical outcomes with intensive therapy for patients with primary resistant multiple myeloma. Bone Marrow Transplant 2004 0.92
15 Asymptomatic Waldenstrom's macroglobulinemia. Semin Oncol 2003 0.89
16 Prognostic implications of tumor cell DNA and RNA content in multiple myeloma. Blood 1985 0.88
17 Consolidation therapy of multiple myeloma with thalidomide-dexamethasone after intensive chemotherapy. Ann Oncol 2002 0.85
18 Treatment of Waldenstrom macroglobulinemia with 2-chlorodeoxyadenosine. Ann Intern Med 1993 0.85
19 Randomized trial of alpha-interferon or dexamethasone as maintenance treatment for multiple myeloma. Am J Hematol 2000 0.84
20 Primary therapy of multiple myeloma with paclitaxel (taxol). Ann Oncol 1994 0.84
21 Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue. J Clin Oncol 1997 0.80
22 Early myeloablative therapy for multiple myeloma. Blood 1994 0.80
23 Primary therapy of Waldenström's macroglobulinemia with 2-chlorodeoxyadenosine. J Clin Oncol 1994 0.79
24 Limited value of myeloablative therapy for late multiple myeloma. Blood 1994 0.78
25 Intensive sequential therapy for VAD-resistant multiple myeloma. Leuk Lymphoma 1994 0.75